Spinal device firm Surgalign Holdings Inc. has paid $2m to the US Securities and Exchange Commission, resolving financial fraud charges.
Surgalign Pays $2M To Resolve SEC Investigation
US financial regulators said that the spinal device company falsely attributed future sales to the current quarter as a way to disguise lower-than-expected sales.
